Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo

被引:103
作者
Bausch, DG
Borchert, M
Grein, T
Roth, C
Swanepoel, R
Libande, ML
Talarmin, A
Bertherat, E
Muyembe-Tamfum, JJ
Tugume, B
Colebunders, R
Kondé, KM
Pirard, P
Olinda, LL
Rodier, GR
Campbell, P
Tomori, O
Ksiazek, TG
Rollin, PE
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Inst Trop Med, Antwerp, Belgium
[3] WHO, CH-1211 Geneva, Switzerland
[4] Natl Inst Communicable Dis, Johannesburg, South Africa
[5] Minist Hlth, Kinshasa, DEM REP CONGO
[6] Inst Pasteur, Cayenne, French Guiana
[7] Le Pharo, Marseille, France
[8] Uganda Virus Res Inst, Entebbe, Uganda
[9] WHO, AFRO, Harare, Zimbabwe
[10] Doctors Borders, Brussels, Belgium
[11] Doctors Borders, Amsterdam, Netherlands
关键词
D O I
10.3201/eid0912.030355
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We conducted two antibody surveys to assess risk factors for Marburg hemorrhagic fever in an area of confirmed Marburg virus transmission in the Democratic Republic of the Congo. Questionnaires were administered and serum samples tested for Marburg-specific antibodies by enzyme-linked immunosorbent assay. Fifteen (2%) of 912 participants in a general village cross-sectional antibody survey were positive for Marburg immunoglobulin G antibody. Thirteen (87%) of these 15 were men who worked in the local gold mines. Working as a miner (odds ratio [OR] 13.9, 95% confidence interval [CI] 3.1 to 62.1) and receiving injections (OR 7.4, 95% CI 1.6 to 33.2) were associated with a positive antibody result. All 103 participants in a targeted antibody survey of healthcare workers were antibody negative. Primary transmission of Marburg virus to humans likely occurred via exposure to a still unidentified reservoir in the local mines. Secondary transmission appears to be less common with Marburg virus than with Ebola virus, the other known filovirus.
引用
收藏
页码:1531 / 1537
页数:7
相关论文
共 38 条
  • [1] BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997
  • [2] Bertherat E, 1999, Med Trop (Mars), V59, P201
  • [3] VIRAL HEMORRHAGIC-FEVER ANTIBODIES IN ZIMBABWE SCHOOL-CHILDREN
    BLACKBURN, NK
    SEARLE, L
    TAYLOR, P
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1982, 76 (06) : 803 - 805
  • [4] A cluster of Marburg virus disease involving an infant
    Borchert, M
    Muyembe-Tamfum, JJ
    Colebunders, R
    Libande, M
    Sabue, M
    Van der Stuyft, P
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2002, 7 (10) : 902 - 906
  • [5] EBOLA VIRUS-INFECTION IN MAN - A SEROLOGICAL AND EPIDEMIOLOGICAL SURVEY IN THE CAMEROONS
    BOUREE, P
    BERGMANN, JF
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1983, 32 (06) : 1465 - 1466
  • [6] BOWEN ETW, 1978, EBOLA VIRUS HAEMORRH, P143
  • [7] GEAR JHS, 1982, YALE J BIOL MED, V55, P207
  • [8] OUTBREAK OF MARBURG VIRUS DISEASE IN JOHANNESBURG
    GEAR, JSS
    CASSEL, GA
    GEAR, AJ
    TRAPPLER, B
    CLAUSEN, L
    MEYERS, AM
    KEW, MC
    BOTHWELL, TH
    SHER, R
    MILLER, GB
    SCHNEIDER, J
    KOORNHOF, HJ
    GOMPERTS, ED
    ISAACSON, M
    GEAR, JHS
    [J]. BRITISH MEDICAL JOURNAL, 1975, 4 (5995) : 489 - 493
  • [9] GONZALEZ J-P, 1983, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V21, P119
  • [10] ANTIBODY PREVALENCE AGAINST HEMORRHAGIC-FEVER VIRUSES IN RANDOMIZED REPRESENTATIVE CENTRAL AFRICAN POPULATIONS
    GONZALEZ, JP
    JOSSE, R
    JOHNSON, ED
    MERLIN, M
    GEORGES, AJ
    ABANDJA, J
    DANYOD, M
    DELAPORTE, E
    DUPONT, A
    GHOGOMU, A
    KOUKABEMBA, D
    MADELON, MC
    SIMA, A
    MEUNIER, DMY
    [J]. RESEARCH IN VIROLOGY, 1989, 140 (04): : 319 - 331